Member Info for Mambamentality

Good interview. Everything seems set for 2021 to be a good year for EQT. I really like that the technology is patented. I think many people investing in PHE do not know that they have not a patent.
Anyone knows how are the finances of the company. It seems the loss they made last year was much more than they were expecting. Thanks

I guess the problem with the loss is that we do not know how much is it?

The view was: "For the year to end-December 2020 he estimates that sales revenues were up from €1.7m to €2.4m, generating a smaller pre-tax loss of €2.3m against €3.7m previously".

"the Company expects to report a loss not lower than €4 million before any potential one-off adjustments".

Thus, although the update is pretty good in most fronts it is to be seen what is the actual loss.

The only thing I would add to what already has been said is that Brad confirmed that any OMI is benefiting from the expertise of Newmont and Agnico. They are pretty much involved in any decision made. Thus, mobilising the fourth rig and the 7000 metres additional drilling shows that the JV partners are happy to accelerate the campaign.

The involvement of Agnico Eagle actually was a blessing as regard VMS Deposits. Agnico Eagle’s own flagship VMS mine, the LaRonde Complex, (‘LaRonde’)is located in the Abitibi region of north-western Quebec. The experience Agnico gained from working with such mineralisation is now providing Orosur with important guidance regarding next steps to be taken.

Brad explained the advantage of having ANZA in Colombia as opposed to Canada or Australia. Margins are easier to achieve in Colombia. So far they have only scratched the surface and it looks like what is there economically have enough value to mine. It would not be marginal operation.

Next results should include several holes. At least 77, 78 and 80. This is probably better than one hole at the time.

The situation with the LAB is getting better and we could see an improvement in the following months. It is not possible to change Laboratories.

Until now the work had been concentrated in the centre - APTA. But, this is changing an people are to be deployed to the field to carry out further geological work at the other tagets we can access.

The process to convert licenses into granted applications should accelerate now.

I guess tomorrow we will find out whether the new 7000m of drilling which is underway it is concentrating only in APTA. We know that the 2400m program was designed to address outstanding orientation and structural questions, as well as to provide insight into the style of mineralisation with a focus on the potential for a hybrid polymetallic VMS/Epithermal model. In that sense the program was successful allowing OMI to understand the nature of the mineralisation and to allow it to accurate targeting/efficient expansion drilling.

In that sense I think that the next 7000m could provide the best results for APTA to date. We shall see. But, with four drills drilling and news expected in other fronts such as licenses we should not have a month without an RNS in the next couple of months.

Can someone please tell me why ALBA is a better investment than OMI? After watching the webinar I fail to see how that is the case? Specially as Greenland is not accessible because of COVID and the weather while Medellin is known as the city of eternal spring.

Good to receive the approval of John Meyer. "Very high gold intersections. Looks really good. Pretty good intersections. Also some poly-metallic side of things. From an exploration perspective that is looking quite exiting".

Mark Watson-Mitchell on 08 February 2021 wrote

"Until further news is known or declared I put the shares out on a target price of just 3p, which offers 36% upside and could well be achieved in a very short timeframe".

Since then the Billingham Land Purchase Agreement occurred and now this Collaboration Framework Agreement with Toyota Motor Manufacturing UK.

Thus, the valuation should be above 3p in the short term. Once the resistance at 2.17p is broken this should move to 3p.

https://masterinvestor.co.uk/equities/eqtec-for-lovers-of-penny-shares-this-really-is-a-sustainable-proposition/

Looking at some previous posts, I can see that some people have compared this stock to other companies such as ZOE. The comparison is wrong as we are a biopharma company creating products to fight diseases. The market for Alzheimer and Dementia is estimated at $13.3 billion by 2023.

Anyone who has been following companies trying to develop a treatment for covid 19 knows that:

1. A treatment for COVID will be needed in the future as COVID is here to stay even after vaccination.
2. Patients infected with COVID-19 develop an uncontrolled immune response ("cytokine storm") resulting in severe damage to lung tissue which could lead to respiratory failure. cytokine storm is the dangerous and fatal phase of the disease.
3. cytokine storm happens in other diseases such as arthritis, Influenza and some types of cancer.
4. Stopping or reducing the cytokine storm has been found to be beneficial to patients infected by COVID 19. See TILS results and also our own results.

Listening to the VOX Market's interview, I can see why the CEO is so exited about the phase 2B results for Artemic. At minute 7 of the recording he says "results have been really really great. We are talking about full double blind placebo... and Artemic what has done is it has halted the cytokine storm".

Currently a version of Artemic is being sold as a food supplement while stage three trials are complete which will allow MGC to sell it as a medication. As above this could be not only for COVID.
MGC has three main products but it is fast tracking Artemic as MGC has become part of the WHO task force for covid, so it has a lot of support globally to develop and fastback the product.

Other two products:
CannEpil - starting phase 2B. Also trying to bring the product to the market.

CogniCann: Alzheimer's disease is the most common cause of dementia, which affects millions of people worldwide.

Also have some oncology products which are in development.

The fact that the company can have products in clinical trials while selling some of the products is a fantastic advantage compared to the regular pharma company.

After researching the tree Cannabis stock's companies which listed in the LSE, this was the one where I can see more potential and I am glad I invested. I can see why in the interview the CEO says that we are like Johnson & Johnson or Pfizer 100 year ago. The potential is huge.

In Frankfurt still going up. I guess once we clear the sellers at 2p we can keep moving north.

Back on the 8 February 2021 the analyst put a 3p target price. All energy stocks but after a good correction these price seems to be a good entry.

"Until further news is known or declared I put the shares out on a target price of just 3p, which offers 36% upside and could well be achieved in a very short timeframe.
For the year to end-December 2020 he estimates that sales revenues were up from €1.7m to €2.4m, generating a smaller pre-tax loss of €2.3m against €3.7m previously.
That might look scary to you – however, the following might attract you to the company and its potential.
For the current year Arden is going for sales to leap over 20 times to €48.1m, then next year almost doubling to €80.6m, producing pre-tax profits of €7.4m then €13.8m respec-tively.
Now that really is an impressive leap forward and why I rate the shares of this penny stock as being capable of rising significantly".

https://masterinvestor.co.uk/equities/eqtec-for-lovers-of-penny-shares-this-really-is-a-sustainable-proposition/

On a positive note the price of Gold seems to have found the bottom. I recovery above $1700 will be a good indicator. Most gold stocks have declined sharply following the price of gold, so we should see some recovery if the price of gold continues to increase.

3 or 4 market makers are looking for stock at 20.50p and only one is selling. This is positive for a share. Do not give your shares on the cheap. See minute 12 of the video. The dip keeps getting bought too which is also a good sign.

https://twitter.com/profitseeker68/status/1368177009902370824

We got a pretty Strong support level at 20.50p to 21p. We have recovered three times from here in the past thus, not a good idea to sell. I got more last Friday. The only time we lost this support level was after the placing at 17p which was normal.

We should receive some news shortly to boost the share price but for the moment it is important not to lose this support level. BUY/HOLD

"What can investors expect from ARB shares in the rest of the year? As Argo's fortunes track the returns of Bitcoin, the stock price is likely to be highly volatile. It is a speculative asset that might be appropriate for some portfolios".

https://uk.investing.com/analysis/argo-blockchain--a-ftse-stock-for-cryptocurrency-investors-200461223

It seems this could pay handsomely.

https://masterinvestor.co.uk/equities/johns-mining-journal-featuring-xtract-emmerson-and-controy-gold/

It is reassuring that John Cornford is invested and continues to hold:
" Apart from specifics, many junior miners have come off as gold is dented by rising interest rates, and because a large number of UK small caps have seen their IG margin call limit sharply increased. Xtract Resources (LON:XTR)however has resisted the malaise and remains the share I’m mainly invested in myself, expecting drill results, dripping slowly out, to maintain a steady, if slow, momentum".

https://masterinvestor.co.uk/equities/johns-mining-journal-featuring-xtract-emmerson-and-controy-gold/

Taken from Masterinvestor. By John Cornford
"In the short term however, Solgold (LON:SOLG) will probably stage a bounce from its current depressed level and I think has more potential in the very long term. But I can’t say the same for Greatland Gold (LON:GGP), whose shares I think have seen their palmiest days – at least for some time".

https://masterinvestor.co.uk/equities/johns-mining-journal-featuring-xtract-emmerson-and-controy-gold/

In the short term however, Solgold (LON:SOLG) will probably stage a bounce from its current depressed level and I think has more potential in the very long term. But I can’t say the same for Greatland Gold (LON:GGP), whose shares I think have seen their palmiest days – at least for some time.

https://masterinvestor.co.uk/equities/johns-mining-journal-featuring-xtract-emmerson-and-controy-gold/

Unable to buy in HL.

As usual able to sell as many.

It seems the drop in share price in the Toronto exchange has not been so bad as here. About £0.23 the price there.

Good idea for John Meyer to discuss Orosur in the vox markets podcast next Wednesday or Thursday. I also wrote to Justin.

I will write to the company too suggesting that one of the directors provide an interview following the release of drilling results. That has worked pretty well for Greatland Gold and other companies.